BR0009843A - Método de diagnosticar encefalopatias esponjiformes transmissìveis - Google Patents

Método de diagnosticar encefalopatias esponjiformes transmissìveis

Info

Publication number
BR0009843A
BR0009843A BR0009843-4A BR0009843A BR0009843A BR 0009843 A BR0009843 A BR 0009843A BR 0009843 A BR0009843 A BR 0009843A BR 0009843 A BR0009843 A BR 0009843A
Authority
BR
Brazil
Prior art keywords
encephalopathies
marker protein
test kit
transmissible
spongy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
BR0009843-4A
Other languages
English (en)
Inventor
Matthias Giese
Mark Stephen Rogers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Vetmedica de C V SA
Original Assignee
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Vetmedica de C V SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica GmbH, Boehringer Ingelheim Vetmedica de C V SA filed Critical Boehringer Ingelheim Vetmedica GmbH
Publication of BR0009843A publication Critical patent/BR0009843A/pt
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Patente de Invenção: "MéTODO DE DIAGNOSTICAR ENCEFALOPATIAS ESPONJIFORMES TRANSMISSìVEIS". A invenção diz respeito a um método de diagnose pré-clínica e clínica de encefalopatias esponjiformes transmissíveis, caracterizado pelo fato de que a expressão alterada de uma proteína marcadora é medida. Nas modalidades particulares, no método de acordo com a invenção, a proteína marcadora medida é a proteína de priónio PrP-sen ou interferon gama (IFNy), ou o receptor de laminina (LR) ou o precursor do receptor de laminina (LRP). A invenção também diz respeito a um kit de teste usando anticorpos específicos da proteína marcadora de acordo com a invenção. A invenção ainda diz respeito a um kit de teste usando oligonucleotídeos que são capazes de hibridizar sob condições rigorosas com o ácido nucléico que codifica a proteína marcadora de acordo com a invenção. A invenção ainda diz respeito ao uso de anticorpos ou oligonucleotídeos que são específicos para as proteínas marcadoras acima mencionadas em um método de acordo com a invenção. A invenção também diz respeito ao uso do kit de teste para diagnosticar encefalopatias esponjiformes transmissíveis.
BR0009843-4A 1999-04-21 2000-04-20 Método de diagnosticar encefalopatias esponjiformes transmissìveis Pending BR0009843A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19918141A DE19918141A1 (de) 1999-04-21 1999-04-21 Verfahren zur Diagnose von übertragbaren Spongiformen Enzephalopathien
PCT/EP2000/003605 WO2000065357A1 (en) 1999-04-21 2000-04-20 Method of diagnosing transmissible spongiform encephalopathies

Publications (1)

Publication Number Publication Date
BR0009843A true BR0009843A (pt) 2002-02-13

Family

ID=7905394

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009843-4A Pending BR0009843A (pt) 1999-04-21 2000-04-20 Método de diagnosticar encefalopatias esponjiformes transmissìveis

Country Status (26)

Country Link
US (2) US20030064424A1 (pt)
EP (1) EP1093585A1 (pt)
JP (1) JP2002543389A (pt)
KR (1) KR20020021774A (pt)
CN (1) CN1347501A (pt)
AR (1) AR023553A1 (pt)
AU (1) AU4297400A (pt)
BG (1) BG106021A (pt)
BR (1) BR0009843A (pt)
CA (1) CA2367696A1 (pt)
CO (1) CO5170446A1 (pt)
CZ (1) CZ20013771A3 (pt)
DE (1) DE19918141A1 (pt)
EA (1) EA200101021A1 (pt)
EE (1) EE200100547A (pt)
HK (1) HK1043188A1 (pt)
HU (1) HUP0200777A2 (pt)
ID (1) ID30392A (pt)
IL (1) IL145253A0 (pt)
MX (1) MXPA01010546A (pt)
NO (1) NO20015094L (pt)
PL (1) PL350985A1 (pt)
SK (1) SK15032001A3 (pt)
TR (1) TR200103011T2 (pt)
UY (1) UY26109A1 (pt)
WO (1) WO2000065357A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0026604D0 (en) 2000-10-31 2000-12-13 Roslin Inst Edinburgh Diagnostic method
DE10108099A1 (de) * 2001-02-19 2002-09-12 Cenas Ag Verfahren zum Nachweis spezifischer Proteine und Verwendung
US20030032032A1 (en) * 2001-03-21 2003-02-13 Annelies Resink Early pre-symptomatic prion diagnostic blood test for encephalopathies
WO2002079511A1 (en) * 2001-03-30 2002-10-10 Chronix Biomedical, Inc. Diagnostic detection of nucleic acids
GB0110172D0 (en) * 2001-04-25 2001-06-20 Pa Consulting Services Improved analytical test approach for blood
WO2002097440A2 (de) * 2001-05-29 2002-12-05 Reinhold Kiehl Verfahren zur bestimmung von peptiden/proteinen, massenspektrometrie für metalle und leitfähigkeitsfeststellung
JP4093736B2 (ja) 2001-06-28 2008-06-04 株式会社日立メディコ 核磁気共鳴診断装置および診断システム
GB2379737A (en) * 2001-09-05 2003-03-19 Univ Geneve Diagnostic method for spongiform encephalopathy disease
KR20020033126A (ko) * 2002-03-08 2002-05-04 김용선 병원성 프리온 단백의 n말단의 비효소적 당화반응 최종산물의 검출에 의한 프리온 질환의 진단
WO2004050908A1 (en) * 2002-12-03 2004-06-17 Exonhit Therapeutics S.A. An early pre-symptomatic prion diagnostic blood test for encephalopathies
RU2251699C1 (ru) * 2003-09-25 2005-05-10 Киселев Всеволод Иванович Способ ранней и доклинической диагностики цервикального рака
ES2246113B1 (es) * 2003-10-31 2007-04-01 Consejo Sup. De Invest. Cientificas Procedimiento de deteccion ante-mortem de proteinas prionicas por espectroscopia infrarroja y su uso en el diagnostico de encefalopatias espongiformes transmisibles.
CA2573164A1 (en) * 2004-07-09 2006-01-26 Chronix Biomedical Detection of nucleic acids to assess risk for bovine spongiform encephalopathy
US7309589B2 (en) * 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
EP1749892B1 (en) * 2005-08-02 2008-03-19 Roche Diagnostics GmbH Nucleotide sequence for assessing TSE
US7798645B2 (en) 2006-05-16 2010-09-21 Mark Costin Roser Visual and memory stimulating retina self-monitoring system

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789655A (en) * 1994-05-13 1998-08-04 The Regents Of The University Of California Transgenic animals expressing artificial epitope-tagged proteins
US6008435A (en) * 1994-05-13 1999-12-28 The Regents Of The University Of California Detecting cow, sheep and human prions in a sample and transgenic mice used for same
EP1416280A3 (en) * 1995-09-14 2005-08-10 The Regents of the University of California Antibodies specific for native PrPsc
DK0891552T4 (da) * 1996-04-03 2009-05-04 Stichting Dienst Landbouwkundi Fremgangsmåde til detektion af prionsygdomme
US5834593A (en) * 1996-11-05 1998-11-10 The Regents Of The University Of California Soluble form of PrPSC which is insoluble in native form
DE19648599C1 (de) * 1996-11-23 1998-02-19 Tavira Holdings Ltd Wirkdruckgeber eines Durchflußmessers
US6221614B1 (en) * 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
EP0861900A1 (en) * 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
US5891641A (en) * 1997-02-21 1999-04-06 The Regents Of The University Of California Assay for disease related conformation of a protein
WO1998053838A2 (en) 1997-05-30 1998-12-03 Winnacker Ernst Ludwig A soluble laminin receptor precursor and methods to inhibit its interactions
US6165784A (en) * 1997-10-14 2000-12-26 The United States Of America As Represented By The Secretary Of Agriculture Antibodies for the detection of prion protein as an indication of transmissible spongiform encephalopathies
US5977324A (en) * 1998-02-20 1999-11-02 The Regents Of The University Of California Process for concentrating protein with disease-related conformation
US6528269B1 (en) * 1998-06-22 2003-03-04 Case Western Reserve University Immunological agents specific for prion protein (PRP)
US6166187A (en) * 1999-03-05 2000-12-26 The Regents Of The University Of California Method of concentrating prion proteins in blood samples
GB0119339D0 (en) * 2001-08-08 2001-10-03 Medical Res Council Method

Also Published As

Publication number Publication date
AR023553A1 (es) 2002-09-04
TR200103011T2 (tr) 2002-02-21
IL145253A0 (en) 2002-06-30
MXPA01010546A (es) 2002-06-04
CA2367696A1 (en) 2000-11-02
WO2000065357A1 (en) 2000-11-02
CN1347501A (zh) 2002-05-01
NO20015094D0 (no) 2001-10-19
KR20020021774A (ko) 2002-03-22
US20030064424A1 (en) 2003-04-03
SK15032001A3 (sk) 2002-02-05
NO20015094L (no) 2001-12-17
BG106021A (en) 2002-06-28
CO5170446A1 (es) 2002-06-27
PL350985A1 (en) 2003-02-24
US20030129667A1 (en) 2003-07-10
ID30392A (id) 2001-11-29
HK1043188A1 (zh) 2002-09-06
EP1093585A1 (en) 2001-04-25
AU4297400A (en) 2000-11-10
EE200100547A (et) 2003-02-17
EA200101021A1 (ru) 2002-04-25
UY26109A1 (es) 2000-12-29
JP2002543389A (ja) 2002-12-17
DE19918141A1 (de) 2000-10-26
CZ20013771A3 (cs) 2002-03-13
HUP0200777A2 (en) 2002-06-29

Similar Documents

Publication Publication Date Title
BR0009843A (pt) Método de diagnosticar encefalopatias esponjiformes transmissìveis
BR0112602A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
BR0011369A (pt) Método de detecção precoce de uma infecção flaviviral, kit de diagnóstico precoce, processo de purificação da protéina ns1 de um flavivìrus composição imunogese, utilização da proteìna ns1, de pelo menos um anticorpo monoclonal anti-ns1, e, processo de expressão de um polinucleotìdeo codificado para a proteìna ns1 de um vìrus da dengue
Bowers et al. Connective tissue‐associated proteins in crevicular fluid: Potential markers for periodontal diseases
ES2160709T3 (es) Uso de lipocalina de neutrofilos humanos (hnl) como un marcador de diagnostico y preparacion de anticuerpo anti-hnl.
WO2003070894A3 (en) A non-invasive diagnostic test utilizing histone modification markers
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
ATE211171T1 (de) Weitgehend reine rezeptorartige, tgf-beta-1- bindende moleküle und deren verwendungen
CA2264939A1 (en) Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes
WO2002057795A3 (en) Methods of diagnosis and treatment of osteoporosis
ATE460430T1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
DE69531345D1 (de) Rekombinant pgp3, verfahren zu dessen herstellung, und dessen verwendung in der diagnose und therapie
Kalluri et al. COL4A5 gene deletion and production of post-transplant anti-α3 (IV) collagen alloantibodies in Alport syndrome
BR9406223A (pt) Método para determinar em uma amostra a atividade funcional de um componente da coagulação sanguinea método para diagnosticar um disturbio da coagulação/anticoagulação sanguinea preparado de anticorpo linhagem celular uso de fator v subunidades ou fragmentos do mesmo tendo atividade anticoagulante na forma de cofator par apc prepraro de plasma embalado plasma deficiente em atividade anticoagulante de fator v como cofator para apc uso do preparado de anticorpo preparado de proteina s preparado de
Narin et al. Diagnostic value of troponin T in neonates of mild pre-eclamptic mothers
Sivakumar et al. Secretory proteins in the saliva of children
CA2366514A1 (en) Diagnostic and therapeutic use of antibodies against the urokinase receptor
ATE48142T1 (de) Blutprotein, verfahren zu seiner herstellung, antikoerper gegen dieses protein und dieses protein oder diese antikoerper enthaltende pharmazeutische zubereitungen.
CA2406443A1 (en) Method for quantification of akt protein expression
FR2795823B1 (fr) Methodes et kits pour le diagnostic ou le suivi d'une pathologie synoviale ou osteoarticulaire comprenant l'utilisation d'un marqueur specifique de la degradation du tissu synovial
DE60037676D1 (de) Verfahren zur diagnose von rickettsia pulicis
ATE359298T1 (de) Löslicher laminin rezeptor vorläufer und verfahren zur verhinderung von laminins interaktionen
Feigelson et al. Additional data on hepatic function tests in cystic fibrosis
BR0308095A (pt) Teste para anticorpos anti-ingap
Thorner et al. The NC1 domain of collagen type IV in neonatal dog glomerular basement membranes. Significance in Samoyed hereditary glomerulopathy.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]